S

    Sera Prognostics Inc (SERA)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.12
    +0.05 (+2.42%)

    Market Cap: $83.63M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    68%(15/22)
    Avg Surprise
    -4.22%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.14
    Range$-0.18 - $-0.10
    4 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-0.17-21.4%
    60d ago$-0.17-19.1%
    30d ago$-0.17-19.1%
    7d ago$-0.18-28.6%
    Current$-0.14
    Revenue Consensus
    $75000
    Range$0 - $100000
    4 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.18
    Range$-0.25 - $-0.15
    4 analysts
    Revenue Consensus
    $33330
    Range$-91670 - $108330
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.18---
    Sep 26EST
    		-$-0.14---
    Jun 26
    Reported Aug 5
    		$-0.18$-0.14-28.57%Miss-12.5%
    Mar 26
    Reported May 6
    		$-0.17$-0.17+0.00%Beat+15.0%
    Dec 25
    Reported Mar 18
    		$-0.16$-0.19+13.70%Beat+36.0%
    Sep 25
    Reported Nov 13
    		$-0.16$-0.21+23.81%Beat+33.3%
    Jun 25
    Reported Aug 6
    		$-0.16$-0.24+33.33%Beat+36.0%
    Mar 25
    Reported May 7
    		$-0.20$-0.21+4.76%Beat+20.0%
    Dec 24
    Reported Mar 19
    		$-0.25$-0.23-8.70%Miss+0.0%
    Sep 24
    Reported Nov 6
    		$-0.24$-0.22-9.09%Miss-4.3%
    Jun 24
    Reported Aug 7
    		$-0.25$-0.26+3.85%Beat+26.5%
    Mar 24
    Reported May 8
    		$-0.25$-0.27+7.41%Beat+26.5%
    Dec 23
    Reported Mar 20
    		$-0.25$-0.26+3.85%Beat+19.4%
    Sep 23
    Reported Nov 8
    		$-0.23$-0.35+34.29%Beat+34.3%
    Jun 23
    Reported Aug 9
    		$-0.34$-0.36+5.56%Beat+8.1%
    Mar 23
    Reported May 10
    		$-0.34$-0.38+10.53%Beat+15.0%
    Dec 22
    Reported Mar 22
    		$-0.31$-0.37+16.22%Beat+24.4%
    Sep 22
    Reported Nov 9
    		$-0.35$-0.62+43.55%Beat+10.3%
    Jun 22
    Reported Aug 10
    		$-0.37$-0.41+9.76%Beat+88.3%
    Mar 22
    Reported May 10
    		$-0.40$-0.37-8.11%Miss-135.3%
    Dec 21
    Reported Mar 29
    		$-0.41$-0.29-41.38%Miss+76.0%
    Sep 21
    Reported Nov 9
    		$-0.39$-0.25-56.00%Miss+73.7%
    Jun 21
    Reported Jul 16
    		$-3.17$-1.26-151.59%Miss-
    Mar 21
    Reported Jun 2
    		$-0.17$-0.17+0.00%Beat-
    Dec 20
    Reported Mar 31
    		$-1.71$0.00N/AMiss-
    Dec 19
    Reported Mar 30
    		$-1.48$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-3.16EV/EBITDA-0.61x
    Price/FCF-3.80xFCF Yield-26.30%
    Profitability
    Profit Margin0.00%Operating Margin-33347.00%
    ROE-45.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-4746.57x
    Current Ratio1.98xQuick Ratio1.98x
    Trading Statistics
    Beta0.98Avg Volume29.66K
    52-Week High$3.9552-Week Low$1.56

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.08
    SMA 20$2.04
    SMA 50$2.02
    SMA 200$2.40
    EMA 10$2.08
    EMA 20$2.06
    EMA 50$2.04
    EMA 200$2.31

    MACD

    Line: 0.02Signal: 0.01Hist: 0.01

    ADX

    ADX: 13.3+DI: 21.0-DI: 15.2

    Aroon & PSAR

    Aroon Up80.0
    Aroon Down36.0
    PSAR$1.96

    Bollinger Bands

    Upper Band$2.19
    Lower Band$1.88
    %B Position1511%(Upper)
    Band Width0.76

    RSI (14-Day)

    Neutral
    54.7

    Momentum Oscillators

    Stoch %K56.4
    Stoch %D59.6
    Williams %R-30.3
    ROC (10d)8.7%
    Momentum0.17
    CCI (20d)98.7
    MFI (14d)47.2

    Volatility Measures

    ATR (14d)$0.13(6.2%)
    StdDev (20d)0.08
    Hist Vol50.5%(High)

    Volume Flow

    VWAP$2.13
    OBV5.8M
    AD Line3.6M
    CMF (20d)-0.030

    Volume Metrics

    Avg Vol (20d)30.4K
    Vol Ratio0.3x(Low)
    VWMA (20d)$2.02

    Pivot Points

    R3$2.13
    R2$2.11
    R1$2.09
    Pivot Point$2.07
    S1$2.05
    S2$2.03
    S3$2.01

    Advanced Oscillators

    TSI5.13
    Ultimate Osc47.9
    KST16.39

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$30,000$14,000$10,000$16,000$17,000$38,000$24,000$29,000$24,000$0$41,000$42,000
    Cost of Revenue$0$0$42,000$0$0$0$32,000$0$0$0$236,000$0
    Gross Profit$30,000$14,000$10,000$16,000$17,000$38,000$24,000$29,000$24,000$0$41,000$42,000
    Operating Expenses$10.03M$9.33M$8.92M$8.96M$9.34M$9.25M$9.41M$8.88M$9.26M$9.08M$8.87M$8.18M
    R&D$3.49M$3.03M$3.22M$3.28M$3.34M$3.33M$3.14M$3.50M$4.41M$3.68M$3.90M$3.54M
    SG&A$4.25M$4.29M$4.04M$4.08M$4.14M$4.44M$4.01M$4.20M$3.75M$4.17M$3.67M$3.29M
    Operating Income$-10,004,000$-9,360,000$-8,954,000$-8,980,000$-9,320,000$-9,250,000$-9,423,000$-8,862,000$-9,253,000$-9,097,000$-8,848,000$-8,184,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$2,000$2,000$1,000$2,000$2,000$4,000$6,000$5,000$8,000$9,000$11,000$14,000
    Income Before Tax$-9,139,000$-8,399,000$-7,881,000$-7,814,000$-8,046,000$-8,187,000$-8,579,000$-7,919,000$-8,303,000$-8,097,000$-7,925,000$-7,210,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-9,139,000$-8,399,000$-7,881,000$-7,814,000$-8,046,000$-8,187,000$-8,579,000$-7,919,000$-8,303,000$-8,097,000$-7,925,000$-7,210,000
    EBITDA$-8,888,000$-8,137,000$-7,570,000$-7,444,000$-7,655,000$-7,818,000$-8,216,000$-7,570,000$-7,947,000$-7,737,000$-7,567,000$-6,848,000
    EBIT$-9,137,000$-8,397,000$-7,880,000$-7,812,000$-8,044,000$-8,183,000$-8,573,000$-7,914,000$-8,295,000$-8,088,000$-7,914,000$-7,196,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SERA

    News

    Form 8K Sera Prognostics Inc For: 19 August By Investing.com

    This article reports on Sera Prognostics Inc.'s Form 8K filing for August 19th. The content is brief and primarily serves as a notification of the filing, without providing detailed information about the 8K's contents. It includes financial market data and popular news articles as supplementary content.

    Investing.com Canada•8/20/26•
    Neutral

    SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER

    Sera Prognostics Inc., a company focused on maternal and neonatal health, has appointed Scott Gleason as its new Chief Financial Officer, effective August 31, 2026. Gleason brings over 25 years of experience in healthcare, diagnostics, and capital markets to the role. Austin Aerts, the previous CFO, will transition to an advisory capacity, continuing to support the company's strategic initiatives.

    Sahm•8/19/26•
    Bullish

    abrdn Group holds 7.21% of Sera Prognostics (SERA) stock

    abrdn Group plc and its subsidiary abrdn Inc. have reported a beneficial ownership of 7.21% in Sera Prognostics, Inc.'s Class A common stock, totaling 2,753,525 shares as of June 30, 2026. Both entities share voting and dispositive power over these shares, which are held on behalf of underlying clients. This filing, a SCHEDULE 13G/A, indicates a passive investment.

    Stock Titan•7/15/26•
    Neutral

    Sera Prognostics grants RSUs and options to director | SERA Insider Trading

    Sera Prognostics (SERA) director Joshua Phillips received equity compensation awards on July 10, 2026, as detailed in a Form 4 filing. These awards include RSUs for 2,260 and 22,426 Class A shares and stock options for 3,477 and 34,494 shares with an exercise price of $1.97. The RSUs vest by July 10, 2027, or the next annual meeting, while the stock options vest monthly over one year and expire in 2036, all contingent on continued service.

    Stock Titan•7/15/26•
    Neutral

    Sera Prognostics (SERA) director receives RSU and stock option grants

    Sera Prognostics, Inc. director Mirza Mansoor Raza received equity awards on July 10, 2026, including Restricted Stock Units (RSUs) for 1,771 and 22,426 shares of Class A common stock, and stock options for 2,725 and 34,494 shares at an exercise price of $1.97. These awards are part of the company's non-employee director compensation policy and 2021 Equity Incentive Plan, with vesting tied to continued service until specific dates or the next annual meeting. No stock sales were reported in this transaction.

    Stock Titan•7/14/26•
    Neutral

    Frequently Asked Questions About SERA

    Does SERA pay dividends?
    Sera Prognostics Inc (SERA) does not currently pay a regular dividend.
    What is SERA's market cap?
    Sera Prognostics Inc (SERA) has a market capitalization of $83.63M with a current stock price of $2.12.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In